CRISPR is the most powerful tool to edit genes with in history, allowing for miraculous or devastating results depending on how it is used. An anti-CRISPR tool was already found before, which prevents the method from making any unwanted mutations. Now, scientists have found an actual off switch so that the tool can be rendered useless.
The switch was found by researchers at the University of California, San Francisco within particular bacterial viruses, Phys.org reports. The new discovery has staggering implications on genetics and advanced medical technology since it allows scientists to have significantly more control over the powerful tool than before.
The study was led by Benjamin Rauch, the first author and Joseph Bondy-Denomy, the senior author. The results were published in a paper in the journal Cell.
The source of the switch is the Listeria monocytogenes, where up to four proteins that can make CRISPR ineffective were found. What’s more interesting is the fact that the CRISPR system that the proteins target is the Streptococcus pyogenes, which is the one that most researchers use. This makes the anti-CRISPR discovery a more all-encompassing solution to a serious problem in gene editing, Genome Web reports.
"Just as CRISPR technology was developed from the natural anti-viral defense systems in bacteria, we can also take advantage of the anti-CRISPR proteins that viruses have sculpted to get around those bacterial defenses," Rauch explained.
As to what effects and benefits this new tool could have, the answer has to do with some of the unintended consequences of an editing tool that can have a large area of effect. By adding the new anti-CRISPR system into the editing treatments that researchers use, it’s basically like creating a narrower, sharper scalpel for surgery. This leads to fewer risks of unnecessary cuts and allows for more expedient gene editing.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



